Regenerex gets new CEO, new funding and new name: Talaris Therapeutics

FIERCE BIOTECH: As it gears up to move its lead cell therapy into phase 3, Regenerex has closed a $100 million financing, built out its leadership team and renamed itself Talaris Therapeutics after the winged sandals worn by the Greek messenger god Hermes. FULL STORY